U.S. Senate · 117th Congress · S. 3974
Ending Discrimination in COVID–19 Treatments Act
A bill to prohibit the consideration of patients' race, color, religion, sex, national origin, age, disability, vaccination status, veteran status, or political ideology or speech in determining eligibility for monoclonal antibody doses distributed by the Federal Government.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Ted CruzR-TX
- Introduced
- March 31, 2022, in the Senate
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (0)
No member has cosponsored this bill.